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Background: Intestinal ischemia is a common complication of intestinal obstruction and arises from impaired
perfusion. The resultant local and systemic inflammatory response and bacterial translocation come with a
significant degree of morbidity and mortality. This study therefore aimed to investigate the predictive value of
elevated levels of serum lactate and phosphate as biomarkers of intestinal ischemia among patients with
mechanical intestinal obstruction.
Methods: This was a cross-sectional analytical study done at Mulago Hospital in Uganda. Ethical approval was
obtained. All eligible patients had a blood sample drawn for assay analysis. Determination of bowel ischemia status
was by physical examination at laparotomy. Analyses were performed using Stata software, version 10.1, and 2 × 2
tables were used to calculate sensitivity and specificity.
Results: Serum lactate was predictive of bowel ischemia, while phosphate was not. Of the 81 patients enrolled 70
qualified for analysis; 40/70 (57%) had ischemic bowel, while 30/70 (43%) had normal bowel. Among those with
ischemic bowel, 28/40 (70%) had reversible ischemia, and 12/40 (30%) had irreversible ischemia. Serum lactate assay
had a sensitivity of 66% and specificity of 53% for bowel ischemia in general and a higher sensitivity of 71% and
specificity of 80% for irreversible bowel ischemia.
Lactate was predictive of bowel ischemia in general (p = 0.011), PPV = 14%, but more significantly predictive of
irreversible ischemia (p = 0.009), PPV = 42%. NPV for lactate in both forms of ischemia was 93%. Hernias (33/70, 47%)
were the most common cause of intestinal obstruction.
Conclusion: Serum lactate assay had moderate sensitivity for bowel ischemia due to acute mechanical intestinal
obstruction. The assay can be used to aid diagnosis of bowel ischemia in low technology settings.
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The diagnosis of intestinal ischemia is still a major chal-
lenge in sub-Saharan Africa where the acute form of intes-
tinal ischemia caused by intestinal obstruction is most
prevalent [1-4]. It is more fatal than the chronic type,
therefore requiring early diagnosis and intervention [5,6].
Mechanical intestinal obstruction, the most common
cause of bowel ischemia in our setting [1-4], is on the in-
crease. The most common causes of intestinal obstruction
are strangulated/obstructed hernia (40-50%), sigmoid* Correspondence: kintu2r@yahoo.co.uk
Surgery Department, School of Medicine, Makerere University, P.O. Box 7072,
Kampala, Uganda
© 2013 Kintu-Luwaga et al.; licensee Springer. T
Commons Attribution License (http://creativeco
reproduction in any medium, provided the origvolvulus (20%) and adhesions (15-12% of admissions)
[3,4]. From recent studies, postoperative adhesions in par-
ticular are responsible for up to 40% of patients with intes-
tinal obstruction seen at Mulago Hospital [2]. The most
common cause of mechanical bowel obstruction and is-
chemia in western populations is adhesions.
Clinically useful markers of early gut ischemia would
allow for more effective treatment and monitoring,
which in turn would reduce the current high morbidity
and mortality (10-40%) [1-10]. Efforts to identify an
appropriate marker for bowel ischemia have been unsat-
isfactory and mainly done among western world subjects
who have a fairly different spectrum of causes, epidemiologyhis is an open access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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whereas in resource-limited settings there may be no or only
a plain abdominal x-ray as the only available investigation
[5-7,10-14]. The epidemiological, genetic and clinical dispar-
ities [12-14] are based on the predisposition to causes such
as adhesive intestinal obstruction, differences in studied age
groups and race-associated genetic differences.
Serological biomarkers such as serum lactate and
phosphate have been found useful and for now seem to
offer some hope for solving diagnostic challenges associ-
ated with intestinal obstruction and ischemia [12-14].
These two markers are released locally when the gut
undergoes ischemic injury and increase in blood circula-
tion as the injury advances. They possess a combination
of qualities such as ready availability, affordability and
user friendliness, and they are minimally invasive. This
study therefore sought to determine the diagnostic ac-
curacy of serum lactate and serum phosphate levels in
patients with bowel ischemia due to mechanical intes-
tinal obstruction in a resource-limited setting.
Methods
Study design
This was a cross-sectional analytical study.
Study setting
Mulago National Referral Hospital is the main teaching
Hospital for Makerere University College of Health Sci-
ences in Kampala. It is situated in Kampala, the capital
city of Uganda, and has a 1,500-bed capacity, admitting
up to 50 patients daily with various surgical emergencies
to its Accident and Emergency Unit.
Study period
The study was conducted from January to May 2012
inclusive.
Study population
All patients admitted to the emergency and general sur-
gical wards with a diagnosis of mechanical intestinal ob-
struction were included.
Patients with potential causes of lactic acidosis, such
as diabetic ketoacidosis, severe hypotension, and renal
and hepatic failure, were excluded. Patients on antiretro-
viral drugs, especially stavudine, and those who died or
whose symptoms resolved just before surgery, and those
younger than 1 year were also excluded.
Data collection
Data were collected using a questionnaire, including
patient demographics and bowel status. Bowel status
was categorized as normal bowel, reversibly ischemic
and irreversibly ischemic bowel, and serum levels of lac-
tate and phosphate were analyzed. Eligible patients werecounseled, consented and recruited by the investigators
and assistants during the perioperative period.
Blood sample handling
Under aseptic techniques, 5 ml of peripheral venous
blood was drawn (avoiding the use of a tourniquet),
2.5 ml delivered to a gray-top fluoride container for lac-
tate and 2.5 ml to a plain red-top container for phos-
phate. Both containers were delivered within 30 min to
the laboratory for analysis or stored in a refrigerator in
standing position at 4°C in cases when delay in delivery
was anticipated. In the laboratory, samples were rou-
tinely centrifuged before analysis for 5 min at 10,000
revolutions per minute to obtain serum. The normal
laboratory reference serum level ranges were 0.5–
2.2 mmol/l for lactate and 0.9–1.5 mmol/l for phosphate
(Mulago Hospital Laboratory).
Scheme for assessment of bowel state
Intraoperatively, the researcher(s) and attending surgeon
physically demonstrated and established the absence or
presence of ischemia or its sequel by observing gut ap-
pearance, texture and the site involved, using clinical judg-
ment that took into consideration the following criteria:
Normal bowel was pink and glistening with normal
peristalsis and normal arterial pulsations or mild alter-
ation of one of them.
Reversible ischemic demonstrated a red, dull sheen
and reduced peristalsis or arterial pulsations that would
improve drastically upon relief of the obstruction.
Irreversible ischemic was dark or black, with a total
loss of sheen and permanent reduction or absence of
peristalsis and arterial pulsations.
These findings were agreed upon by consensus of the
operating surgeon, assistant and investigator(s).
Quality control
Tourniquet use was always avoided when drawing blood
samples. Blood was not drawn from the cannulated limb
(with an i.v. line/drip). Late night samples were kept at
4°C in standing position. All samples were centrifuged in
the laboratory before analysis.
Random on-the-spot lactate measurements (with a port-
able lactate meter) were done before samples were delivered
to the laboratory to serve as a control for the laboratory
measurements. Sample handling was uniform—i.e., trans-
portation and storage were only carried out by the in-
vestigator and one research assistant and the handling
and processing by one and the same qualified laboratory
technologist using the same well-calibrated machine,
Cobas Intergra 400 (Roche), based on an accredited
(SANAS) laboratory in Mulago Hospital. Centrifuged sam-
ples (serum) were frozen at −20°C in case of the need for
sample reruns.
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Analyses were performed using Stata software, version
10.1. Statistical tests included Mann-Whitney U and
Fischer’s exact tests. The Kruskal-Wallis equality-of-
population rank test was used for independent analysis
of factors across three groups defined by bowel status
(normal, reversibly ischemic and irreversibly ischemic
bowel). Cox regression analysis was used in both univar-
iate and multivariate models. Significant p values were
≤0.05. Two-by-two tables were used to calculate the sen-
sitivity and specificity expressed as percentages.
Ethical considerations
Approval was obtained from the Research and Ethics
Committee of Makerere College of Health Sciences,
School of Medicine. Informed written consent was ob-
tained from all participants and parental consent for all
below 18 years. Those who were incapacitated at the
time of data collection were consented later when they
were able to consent.
Results
In this study, 81 patients who fulfilled the criteria were
enrolled. Seventy of them had the outcome of interest,
and their data were analyzed. Eleven patients were ex-
cluded because they had concomitant non-ischemic con-
ditions such as gut perforations, which were not a result
of prior obstruction.
Table 1 shows evidence of differences in the distribu-
tion of symptoms and physical examination findings.
More males were seen (53; 65%) compared to women
(28; 35%), and proportionately more males had both
normal and ischemic bowel intraoperatively. The median
age group was 38 years (IQR 52-25); however, those withTable 1 Characteristics of patients with bowel ischemia, Ugan
Baseline characteristic N = 70 (100%) total number Norm
Gender, n (%)
Female 24 (34) 7 (23)
Male 46 (66) 23 (77
Age (years), median (IQR) 38 (52–25) 36 (45
Symptom duration, median (IQR)
Abdominal pain 72 (120–36) 48 (96
Absolute constipation 48 (96–24) 48 (84
Relative constipation 24 (48–12) 18 (24
Abdominal swelling 72 (96–24) 48 (72
Vomiting 48 (96–24) 24 (96
Biomarker levels
Lactate (mmol/l), median (IQR) 1.72 (2.46-1.26) 1.66 (2
Phosphate (mmol/l), median (IQR) 1.30 (1.70-1.10) 1.20 (1
*Mann-Whitney U test, **Fisher’s exact test. Biomarker values measured by Mulagoischemic bowel had a median age of 42 (IQR 64–24),
relatively older than those with normal bowel (36 years;
IQR 45–25). Patients with bowel ischemia had longer
duration of symptoms than those with normal bowel,
and the majority of patients with bowel ischemia had
most of the signs. There were differences in the distribu-
tion of biomarkers. Biomarker levels were higher in pa-
tients with bowel ischemia than those with normal
bowel as indicated in Figure 1.
A sensitivity of 66% and specificity of 53% for bowel
ischemia in general were found, with a positive predict-
ive value of 14% and negative predictive value of 93%.
For irreversible ischemia, the sensitivity was 71% and
specificity 80%, which correspond to a positive predictive
value of 42% and negative predictive value of 93%. Par-
ticipants with irreversible bowel ischemia had higher
levels of serum lactate compared to normal and revers-
ible bowel ischemia groups. There were no major differ-
ences in phosphate levels across groups, as shown in
Table 2.
With the Kruskal-Wallis equality-of-population rank
test, factors were compared and analyzed independently
among three groups defined by bowel status (normal
bowel vs. reversibly ischemic bowel vs. irreversibly ische-
mic bowel). Significant factors were gender (0.03), ab-
dominal pain duration (0.04), abdominal swelling
duration (0.04) and lactate levels (0.01), as indicated in
Table 3.
Associations with irreversible bowel ischemia were with
gender (p-value, 0.03), while lactate had a persistently sig-
nificant p-value (0.001 and 0.009) in both univariate and
multivariate models, respectively. Phosphate levels were
not significant in both analyses and models, indicating
very low sensitivity and specificity (see Table 3). Sensitivityda study, 2012




–25) 41.5 (64–24) 0.251*
–24) 96 (14–48) 0.012*
–24) 72 (96–48) 0.252*
–12) 36 (72–20) 0.285*
–24) 72 (120–48) 0.011*
–18) 72 (120–24) 0.103*
.1-1.37) 1.77 (2.66-1.21) 0.59*








Normal Reversible Ichemia Irreversible Ischemia
Plot of serum levels lactate and phosphate and viability status of gut
Lactate Phosphate
Figure 1 Box plot of serum levels of lactate and phosphate against bowel status.
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lated using a cutoff 1.5 times the upper normal range of
lactate (2.2 mmol/l) in the two-by-two tables.
The majority of patients had normal bowel (30, 43%),
but they were slightly more than the reversible ischemia
group, which had 28 (40%). For irreversible ischemia
(12/40), gangrene was the most common feature; how-
ever, several patients had a mixed pattern of infarction,
gangrene and necrosis.
The ileum was the main part of the gut involved (52,
72%), followed by the colon (27, 38%), and the omentum
(6, 8.3%) was the least. For all gut parts, there were com-
paratively more patients with ischemic bowel than normal
bowel. Groin hernias were the main cause of intestinalTable 2 Differences in distribution of patient clinical
factors by bowel status
Characteristic/predictor X2 (Df) p-value*
Gender 7.135 (2) 0.028
Age 2.820 (2) 0.244
Symptoms duration (hours)
Abdominal pain 6.450 (2) 0.040
Absolute constipation 1.318 (2) 0.517
Relative constipation 1.894 (2) 0.388
Abdominal swelling 6.556 (2) 0.038
Vomiting 2.723 (2) 0.256
Radiological findings
Air in pelvis 2.723 (2) 0.256
Biomarkers
Lactate levels 9.090 (2) 0.011
Phosphate levels 3.470 (2) 0.176
*Kruskal-Wallis equality-of-populations rank test.obstruction (47%), followed by gut volvulus (23%), then
adhesions (17%) and intussusceptions (14%).
There was a weak correlation between lactate level
and age and a weak negative correlation between phos-
phate level and age. There was no difference in the dis-
tribution of serum levels of lactate and phosphate by
gender. There was no correlation of duration of symp-
toms and serum levels of both lactate and phosphate.
Costs per test were US$ 2 and US$ 3 for lactate and
phosphate assays, respectively.
Discussion
We set out to investigate the diagnostic value of the as-
sociation between serum lactate and phosphate in rela-
tion to bowel ischemia. There was an association
between serum lactate and bowel ischemia, but not be-
tween serum phosphate and bowel ischemia. The popu-
lation studied was mostly male, with a male:female ratio
of 2:1, though the bioassays didn’t vary by gender. The
mean age was 39 years; this would be considered young
in the context of mechanical intestinal obstruction.
Role of biomarkers
The role of serum lactate in predicting bowel ischemia
was modest; it was far below the higher values of sensi-
tivity found by several studies [12,15]. However, the
study by Lange et al. [12] did not specify the degree of
ischemia. For irreversible ischemia, which includes in-
farcted gut, the sensitivity and specificity were much
higher, 71% and 80%, respectively, in this study. This is
close to the findings of Klein et al. where serum lactate
levels were elevated in 77% of all patients with bowel in-
farction [16].
Gearhart et al. found 100% sensitivity for intestinal
ischemia with a combination of alpha-glutathione S-
Table 3 Univariate and multivariate assessment of factors associated with bowel status across two groups, normal vs.
irreversible ischemic bowel, using modified cox regression models for cross-sectional studies
Univariate Multivariate
Characteristic PRR [95%] CI P value PRR [95%] CI P value
Gender: male vs. female 0.264 0.080 - 0.877 0.030 0.251 0.038 - 1.667 0.152
Age 1.019 0.990 - 1.049 0.200 1.028 0.988 - 1.069 0.168
Symptom duration (h)
Abdominal pain 1.000 0.994 - 1.007 0.928 - - -
Absolute constipation 1.002 0.991 - 1.012 0.770
Relative constipation 1.037 0.972 - 1.105 0.272
Abdominal swelling 1.002 0.993 - 1.009 0.677
Vomiting 1.002 0.991 - 1.014 0.688
Signs
Abdominal distension 0 - - - - -
Tenderness 0.961 0 1.000
Bowel sounds - - -
Degree of dehydration - 0.124 - 7.444 0.970
Radiological findings
Bowel loop distension - - 1.000 - - -
Air-fluid levels 0 0 0.238
Air in pelvis 3.500 0.438 - 27.984 -
Biomarkers
Lactate levels 1.357 1.311 - 2.919 0.001 1.391 1.086 - 1.781 0.009
Phosphate levels 1.437 0.865 - 2.388 0.162 0.981 0.464 - 2.074 0.960
PRR = Prevalence rate ratios.
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ity may also be attributed to the use of more rigorous in-
clusion criteria such as the use of a combination of
colonoscopy, angiography and autopsy to confirm the
diagnosis of bowel ischemia. In this study, we only relied
on physical inspection to determine bowel status. The
specificity of 42% by Lange is however closer to the 53%
found in this study.
Phosphate had no association with bowel ischemia in
this study, which is a departure from the findings of
Jamieson [18], who found phosphate to be significantly
increased (in 80% of patients) in massive bowel ischemia.
He however did not define what massive was.
Both biomarker levels were higher in patients with
bowel ischemia than in those with normal bowel, implying
that rising serum levels of lactate and phosphate may
predict bowel ischemia. Although the overall change in
the two biomarker levels was low, it was more significant
for lactate (p = 0.009). For phosphate, it was insignificant
(p = 0.960). The weak correlation with phosphate was fur-
ther confirmed (see Table 3), where the p value was > 0.05.
These findings are comparable to those by Leo [19]
where phosphate sensitivity was as low as 26%. The dif-
ferences in these values ought to be regarded with dueconsideration of the clinical, demographic and geo-
graphical disparities and their impact on human physi-
ology, for instance, with an average symptom duration
of 72 h or 3 days, it is possible that phosphate may have
been cleared in the urine [13].
Bowel ischaemia
The majority of patients had ischemia 40/70 (57%). The
median duration of abdominal pain was 72 h (IQR 120-
36) (p = 0.012); long symptom duration is considered a
risk factor for bowel ischemia [2,4]. Symptom duration
had a correlation with intraoperative findings, specifically
abdominal pain and swelling. Most patients with bowel is-
chemia had the complete symptomatology and had had
symptoms for a longer period of time than those with nor-
mal bowel.
Ileum was the most common part of the gut involved in
the obstruction (52%), mainly contained in obstructed/in-
carcerated hernias, which was also the most prevalent in-
traoperative diagnosis. These findings correspond rather
accurately with those of Kiyengo [20] where the incidence
of ileum to colon involvement was at a 2:1 ratio. In some
cases, more than one part of the gut or accessory organs
would be entrapped in hernias or intestinal volvulus,
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jejunum-ileum and ileum-colon, respectively. The cecum
and appendix were mainly components of intussuscep-
tions. All these parts have been commonly involved in the
various forms of mechanical intestinal obstruction re-
corded before in other studies in Uganda and other parts
of sub-Saharan Africa [1-4,8], whereas a definitive diagno-
sis of mechanical obstruction with features of bowel ische-
mia warrants a laparotomy in situations of adhesive bowel
obstruction; nonoperative measures are employed first
though within time limits of 12–36 h.
In this study the main causes of mechanical intestinal
obstruction were hernias (33%). The reason for the preva-
lence of intestinal obstruction caused by hernias is that
many patients live with untreated hernias as opposed to
western countries where access to care is early. Other
causes included sigmoid volvulus (14%), adhesions and in-
tussusceptions in declining order of proportion. These
study findings are similar to those of MacAdam (1960) [1]
and Watya (1992) [8], who registered hernias as the lead-
ing cause at 54%, sigmoid volvulus at 21% and adhesive
obstruction at 9%. This pattern however is different from
the one reported by Kimuli (2006) [2], in which adhesions
were 40%, followed by sigmoid volvulus at 32%, tumors at
12%, intussusceptions 7% and fecal impaction 7%.
In western countries, mechanical intestinal obstruction
(and the resultant intestinal ischemia) is mainly caused
by post-surgical adhesions in over 60% of cases [21,22].
Study limitations
Though serum lactate is non-specific for bowel ischemia,
it may be useful in settings where high-level investigative
abilities are limited. The physical assessment of bowel
status has limited accuracy (70–89%) [23,24]. The ideal
assessment for bowel ischemia should be histological
(requiring biopsy), which allows assessment of the entire
gut wall including mucosa where the ischemia starts;
this wasn’t feasible though. Some patients with appar-
ently normal or viable bowel could have had raised
levels of serum lactate and phosphate, i.e., ischemia may
have been present in the inner gut layers; type I ischemia
is not appreciable physically. Therefore, this limited this
study to type 2 and 3 bowel ischemia.
Patients with mechanical intestinal obstruction are op-
erated on as soon as they are resuscitated, but some-
times logistical limitations lead to delays. Whereas the
majority of patients did not wait longer than 6 h, it is
possible that during this waiting time significant changes
in bowel status and biomarker levels occurred. From the
single blood sample drawn, it was not possible to ob-
serve the ongoing changes in biomarker levels. Large-
scale studies are needed especially in sub-Saharan Africa
to further explore the role of serum lactate and phos-
phate assays in aiding bowel ischemia diagnosis.Conclusion
Serum lactate assay had moderate sensitivity for bowel
ischemia caused by acute mechanical intestinal obstruc-
tion in a sub-Saharan Africa resource-limited setting.
This assay may augment the diagnosis of bowel ischemia
in the emergency setting.
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